Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer.

To assess the efficacy and toxicity of an outpatient combination chemotherapy in small-cell lung cancer (SCLC), we treated 70 consecutive patients with epirubicin 80 mg m(-2) i.v. on day 1 and etoposide 200 mg o.d. p.o. on days 1-4 (EE) at 3-weekly intervals. The median age of patients was 64 years...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gogas, H., Lofts, F. J., Evans, T. R., Millard, F. J., Wilson, R., Mansi, J. L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 1997
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2228002/
https://ncbi.nlm.nih.gov/pubmed/9303364
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge